Price is what is was before the medicare update was released.. Valuation is significantly off the mark here, I have picked up more today.
- Forums
- ASX - By Stock
- EYE
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-187
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.64M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 15.5¢ | $14.31K | 92.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 148500 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 124195 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 148500 | 0.150 |
8 | 558724 | 0.145 |
11 | 450030 | 0.140 |
2 | 14500 | 0.135 |
6 | 75850 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 124195 | 4 |
0.165 | 119997 | 2 |
0.170 | 200000 | 3 |
0.175 | 100000 | 1 |
0.180 | 100000 | 1 |
Last trade - 12.02pm 13/11/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online